MIM
JSPR icon

Monashee Investment Management’s Jasper Therapeutics JSPR Stock Holding History

Monashee Investment Management’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-17,500
Closed -$1.79M – 217
2020
Q2 		$1.79M Hold
17,500
– – 0.27% 105
2020
Q1 		$1.66M Buy
+17,500
New +$1.71M 0.89% 10

Other funds holding JSPR

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
TCM
Tenor Capital Management New York $6.49B AUM 3.01% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
SRCM
Sage Rock Capital Management New York $22.3M AUM 4.09% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
DCM
Dupont Capital Management Wilmington, Delaware $879M AUM 29.99% 1-Year Est. Return

Monashee Investment Management's JSPR Position: Q3 2020 in Review

Monashee Investment Management sold out of Jasper Therapeutics (JSPR) in Q3 2020, closing a stake of 17,500 shares — an estimated $1.79M sold.

Monashee Investment Management first reported a position in JSPR in Q1 2020 and held it in 2 quarters. The position peaked at $1.79M in Q2 2020. 42 funds tracked by Wall St. Rank hold JSPR as of Q3 2020.

  • Monashee Investment Management reported no remaining Jasper Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Monashee Investment Management sold 17,500 Jasper Therapeutics shares in Q3 2020, an estimated $1.79M.
  • Monashee Investment Management first reported a position in Jasper Therapeutics in Q1 2020 and held it in 2 quarters.
  • Monashee Investment Management's Jasper Therapeutics position peaked at $1.79M in Q2 2020.
  • 42 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2020.

Based on Monashee Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.